Cargando…

Combination of topical liposomal amphotericin B and Glucantime in comparison with glucantime alone for the treatment of anthroponotic cutaneous leishmaniasis (ACL) caused by Leishmania tropica: study protocol for a randomized, controlled trial

BACKGROUND AND OBJECTIVES: Cutaneous leishmaniasis (CL) treatment is a challenging issue, although numerous modalities have been introduced as candidate treatment for CL yet only antimonial agents are commonly used to treat CL, a different form of amphotericin B is used to treat visceral form of lei...

Descripción completa

Detalles Bibliográficos
Autores principales:	Eskandari, Seyed Ebrahim, Khamesipour, Ali, Jaafari, Mahmoud Reza, Javadi, Amir, Mohammadi, Akram Miramin, Valian, Hossein Keshavarz, Nassiri-Kashani, Mansour, Goyonlo, Vahid Mashayekhi, Firooz, Alireza
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Tehran University of Medical Sciences 2021
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8629814/ https://www.ncbi.nlm.nih.gov/pubmed/34900170 http://dx.doi.org/10.18502/ijm.v13i5.7440

Ejemplares similares

Safety Evaluation of Nano-Liposomal Formulation of Amphotericin B (Sina Ampholeish) in Animal Model as a Candidate for Treatment of Cutaneous Leishmaniasis
por: Eskandari, Seyed Ebrahim, et al.
Publicado: (2018)

Unresponsiveness to Glucantime Treatment in Iranian Cutaneous Leishmaniasis due to Drug-Resistant Leishmania tropica Parasites
por: Hadighi, Ramtin, et al.
Publicado: (2006)

Safety Evaluation of Topical Application of Nano-Liposomal Form of Amphotericin B (SinaAmpholeish) on Healthy Volunteers: Phase I Clinical Trial
por: ESKANDARI, Seyed Ebrahim, et al.
Publicado: (2019)

A Comparison between the Effects of Glucantime, Topical Trichloroacetic Acid 50% plus Glucantime, and Fractional Carbon Dioxide Laser plus Glucantime on Cutaneous Leishmaniasis Lesions
por: Jaffary, Fariba, et al.
Publicado: (2016)

A Novel Niosomal Combination of Selenium Coupled with Glucantime against Leishmania tropica
por: Mostafavi, Mahshid, et al.
Publicado: (2019)

Molecular signatures of anthroponotic cutaneous leishmaniasis in the lesions of patients infected with Leishmania tropica
por: Masoudzadeh, Nasrin, et al.
Publicado: (2020)

Efficacy of Topical Liposomal Amphotericin B versus Intralesional Meglumine Antimoniate (Glucantime) in the Treatment of Cutaneous Leishmaniasis
por: Layegh, Pouran, et al.
Publicado: (2011)

Treatment Outcome of the Drug-resistant Zoonotic Cutaneous Leishmaniasis by Glucantime
por: Soleimanifard, Simindokht, et al.
Publicado: (2017)

DECREASED EFFECT OF GLUCANTIME IN CUTANEOUS LEISHMANIASIS COMPLICATED WITH SECONDARY BACTERIAL INFECTION
por: Sadeghian, G, et al.
Publicado: (2011)

The therapeutic effect of ozonated olive oil plus glucantime on human cutaneous leishmaniasis
por: Aghaei, Maryam, et al.
Publicado: (2019)

In Vitro Study of Leishmanicidal Activity of Biogenic Selenium Nanoparticles against Iranian Isolate of Sensitive and Glucantime-Resistant Leishmania tropica
por: MAHMOUDVAND, Hossein, et al.
Publicado: (2014)

Effect of topical honey application along with intralesional injection of glucantime in the treatment of cutaneous leishmaniasis
por: Nilforoushzadeh, Mohammad Ali, et al.
Publicado: (2007)

Comparison of Intralesional Two Percent Zinc Sulfate and Glucantime Injection in Treatment of Acute Cutaneous Leishmaniasis
por: Maleki, Masoud, et al.
Publicado: (2012)

Efficacy of miltefosine compared with glucantime for the treatment of cutaneous leishmaniasis: a systematic review and meta-analysis
por: Iranpour, Sohrab, et al.
Publicado: (2019)

Successful treatment by adding thalidomide to meglumine antimoniate in a case of refractory anthroponotic mucocutaneous leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2019)

Therapeutic Effect of Sodium Selenite and Zinc Sulphate as Supplementary with Meglumine Antimoniate( Glucantime®) Against Cutaneous Leishmaniasis In BALB/C Mice
por: Sorkhroodi, F Zamani, et al.
Publicado: (2010)

Downregulation of Calcineurin Gene Is Associated with Glucantime(®) Resiatance in Leishmania infantum
por: Bagher KHADEM ERFAN, Mohammad, et al.
Publicado: (2013)

Gulucatime versus Glucantime: A Serious Warning on Counterfeit Medicines
por: Abtahi-Naeini, Bahareh, et al.
Publicado: (2019)

In vivo/In vitro immune responses to L. major isolates from patients with no clinical response to Glucantime
por: Saberi, Sedigheh, et al.
Publicado: (2016)

Therapeutic Potential of Green Synthesized Copper Nanoparticles Alone or Combined with Meglumine Antimoniate (Glucantime(®)) in Cutaneous Leishmaniasis
por: Albalawi, Aishah E., et al.
Publicado: (2021)

The effect of oral miltefosine in treatment of antimoniate resistant anthroponotic cutaneous leishmaniasis: An uncontrolled clinical trial
por: Tayyebi, Masoumeh, et al.
Publicado: (2021)

The efficacy of Achilles millefolium topical gel along with intralesional injection of glucantime in the treatment of acute cutaneous leishmaniasis major
por: Jaffary, Fariba, et al.
Publicado: (2014)

Evaluation of synergistic therapeutic effect of shark cartilage extract with artemisinin and glucantime on visceral leishmaniasis in BALB/c mice
por: Molaie, Soheila, et al.
Publicado: (2019)

P-glycoprotein A Gene Expression in Glucantime-Resistant and Sensitive Leishmania major (MRHO/IR/75/ER)
por: SOLEIMANIFARD, Simindokht, et al.
Publicado: (2014)

Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study
por: Hakamifard, Atousa, et al.
Publicado: (2023)

Ocular Leishmaniasis Treated by Intralesional Amphotericin B
por: Nikandish, Malihe, et al.
Publicado: (2016)

In vitro activity of Alkanna frigida extracts in comparison with glucantime against Leishmania major
por: Jafari, Fariba, et al.
Publicado: (2013)

Determinants of Unresponsiveness to Treatment in Cutaneous Leishmaniasis: A Focus on Anthroponotic Form Due to Leishmania tropica
por: Bamorovat, Mehdi, et al.
Publicado: (2021)

Comparison of cytokine profile of IFN-γ, IL-5 and IL-10 in cutaneous leishmaniasis using PBMC vs. whole blood
por: Mohammadi, Akram Miramin, et al.
Publicado: (2019)

Development of a topical liposomal formulation of Amphotericin B for the treatment of cutaneous leishmaniasis
por: Jaafari, Mahmoud Reza, et al.
Publicado: (2019)

Cutaneous Leishmaniasis in Suspected Patients Referred To the Center for Research and Training in Skin Diseases and Leprosy, Tehran, Iran from 2008 To 2011
por: MOHAMMADI, Akram MIR AMIN, et al.
Publicado: (2013)

Efficacy of Intralesional Amphotericin B for the Treatment of Cutaneous Leishmaniasis
por: Goyonlo, Vahid Mashayekhi, et al.
Publicado: (2014)

Efficacy of intra-lesional injections of meglumine antimoniate once a week vs. twice a week in the treatment of cutaneous leishmaniasis caused by L. tropica in Iran: A randomized controlled clinical trial
por: Javadi, Amir, et al.
Publicado: (2022)

Immune response in cutaneous leishmaniasis patients with healing vs. non-healing lesions
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2020)

Population Structure of Leishmania tropica Causing Anthroponotic Cutaneous Leishmaniasis in Southern Iran by PCR-RFLP of Kinetoplastid DNA
por: Ghatee, Mohammad Amin, et al.
Publicado: (2018)

The potential therapeutic role of PTR1 gene in non‐healing anthroponotic cutaneous leishmaniasis due to Leishmania tropica
por: Sezavar, Monireh, et al.
Publicado: (2020)

Immune Responses in Cutaneous Leishmaniasis: In vitro Thelper1/Thelper2 Cytokine Profiles Using Live Versus Killed Leishmania major
por: Miramin-Mohammadi, Akram, et al.
Publicado: (2021)

Evaluation of an immunochemotherapeutic protocol constituted of N-methyl meglumine antimoniate (Glucantime(®)) and the recombinant Leish-110f(®) + MPL-SE(®) vaccine to treat canine visceral leishmaniasis
por: Miret, Jorge, et al.
Publicado: (2008)

Anthroponotic Cutaneous Leishmaniasis, Kabul, Afghanistan
por: Reithinger, Richard, et al.
Publicado: (2003)

Comparison of Proteome Profiling of Two Sensitive and Resistant Field Iranian Isolates of Leishmania major to Glucantime® by 2- Dimensional Electrophoresis
por: ZAREAN, Mehdi, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_91kl0bihn8tmr4df0ko4djfspe